Product image of Labentrol (Ciprofloxacin Lactate) supplied by GNH India

Labentrol

Active Ingredient:
Ciprofloxacin Lactate
Origin:
EU

Labentrol (Ciprofloxacin Lactate)

Ciprofloxacin, the active ingredient in Labentrol, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous administration. It is indicated for the treatment of severe bacterial infections, including urinary tract infections, respiratory tract infections, and skin and soft‑tissue infections, primarily in adult patients.

GNH India supplies Labentrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for injectable products. Customers benefit from consistent batch release and regulatory support across EU and global markets.

Manufacturer / TM Owner

Sja Pharm Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Labentrol (ciprofloxacin) is a fluoroquinolone antibiotic that targets bacterial DNA replication, making it suitable for several serious infections.

  • Severe bacterial infections: achieves rapid bacterial eradication in systemic infections.
  • Urinary tract infections: clears pathogenic bacteria causing cystitis and pyelonephritis.
  • Respiratory tract infections: treats pneumonia and bronchitis caused by susceptible organisms.
  • Skin and soft‑tissue infections: resolves cellulitis, abscesses, and wound infections caused by Gram‑negative and Gram‑positive bacteria.

How It Works

  • Ciprofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By stabilizing the enzyme‑DNA complex, it prevents DNA strand separation, halting bacterial replication and transcription, leading to bacterial cell death. This bactericidal action is effective against a broad spectrum of Gram‑negative and some Gram‑positive organisms.

Side Effects

Ciprofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, sometimes watery.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional vertigo or light‑headedness.
  • Rash: mild skin erythema or pruritus.
  • Injection site pain: local discomfort at the IV site.

Serious or Rare Side Effects

  • Tendon rupture: especially Achilles, may occur without warning.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Severe allergic reactions: anaphylaxis, angioedema.
  • Clostridioides difficile colitis: severe intestinal inflammation.
  • Hepatic toxicity: elevated liver enzymes or jaundice.
  • Seizures: particularly in patients with CNS disorders.

Precautions & Warnings

Ciprofloxacin requires careful assessment before use.

  • Renal impairment: adjust dosing based on creatinine clearance.
  • History of tendon disorders: avoid use due to risk of tendon rupture.
  • Concomitant QT‑prolonging drugs: monitor cardiac rhythm.
  • Pregnancy and lactation: use only if benefits outweigh risks.
  • Known allergy to fluoroquinolones: contraindicated.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Ciprofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: markedly reduce ciprofloxacin absorption.
  • Warfarin: may increase anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely)

  • Theophylline: increased plasma levels may cause toxicity.
  • NSAIDs: heightened risk of central nervous system adverse effects.
  • Corticosteroids: elevated chance of tendon injury.
  • Cyclosporine: may raise cyclosporine concentrations.

Frequently Asked Questions

Labentrol contains ciprofloxacin lactate and is used to treat severe bacterial infections such as urinary tract infections, respiratory tract infections, and skin and soft‑tissue infections. It is administered intravenously in hospital or clinical settings under medical supervision.

Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By blocking these targets, it prevents bacterial cells from multiplying, leading to bacterial death and resolution of the infection.

The dosage of Labentrol is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and other clinical factors. Only a qualified health professional should set the dosing regimen.

Safety data for ciprofloxacin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Labentrol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where needed) and import documentation.

Labentrol (ciprofloxacin) offers a broad spectrum of activity against Gram‑negative and some Gram‑positive bacteria, similar to other fluoroquinolones. Compared with agents like levofloxacin, ciprofloxacin has a slightly different pharmacokinetic profile and may be preferred for certain severe infections requiring intravenous therapy.

Labentrol should be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution to maintain stability and potency.

Labentrol is supplied as an injectable solution for intravenous infusion. It is administered by a qualified healthcare professional, typically diluted in an appropriate IV fluid and infused over a prescribed period, following aseptic technique.

Serious risks include tendon rupture (especially Achilles), QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, hepatic toxicity, and seizures. Patients should be monitored closely for any of these events.

Labentrol is contraindicated in patients with a known hypersensitivity to ciprofloxacin or other fluoroquinolones. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, and used with caution in patients with significant renal impairment or cardiac arrhythmias.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ciprofloxacin Lactate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT